Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered

Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered

Bibliographic Details
Main Authors:	Joel Hanhart, Sohee Jeon, Raimo Tuuminen
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Journal of Diabetes
Online Access:	https://doi.org/10.1111/1753-0407.13468

Similar Items

Should Multifocal Intraocular Lenses Become a Standard in Phacoemulsification Cataract Surgery?
by: Achia Nemet, et al.
Published: (2023-03-01)

Anatomical and Functional Outcomes with Prompt versus Delayed Initiation of Anti-VEGF in Exudative Age-Related Macular Degeneration
by: Assaf Gershoni, et al.
Published: (2023-12-01)

Zoonosis–Why we should reconsider “What's in a name?”
by: Balbir B. Singh, et al.
Published: (2023-02-01)

Should we reconsider the routine use of placebo controls in clinical research?
by: Avins Andrew L, et al.
Published: (2012-04-01)

"Scholarship Reconsidered": Reconsidered
by: Randall Bowden
Published: (2007-10-01)

Advancements in Postoperative Care after Cataract Surgery
by: Piotr Kanclerz, et al.
Published: (2022-06-01)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
by: Eustace, A, et al.
Published: (2013)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
by: Eustace, A, et al.
Published: (2013)

Prediction of clinical trial enrollment rates.
by: Cameron Bieganek, et al.
Published: (2022-01-01)

Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
by: Alexander Aaronson, et al.
Published: (2020-09-01)

Imaging Modalities Employed in Diabetic Retinopathy Screening: A Review and Meta-Analysis
by: Piotr Kanclerz, et al.
Published: (2021-09-01)

Technical failure rates for biometry between swept-source and older-generation optical coherence methods: a review and meta-analysis
by: Piotr Kanclerz, et al.
Published: (2023-04-01)

A DECREE WENT OUT FROM CAESAR AUGUSTUS THAT THE WHOLE WORLD SHOULD BE ENROLLED»
by: Pierluigi Magistri
Published: (2019-11-01)

An Unfortunate Trend of Vagueness - Why Germany Should Reconsider its Position on Functional Immunity Ratione Materiae
by: Florian Schmid
Published: (2024-02-01)

Indication of Liver Transplantation for Hepatocellular Carcinoma Should Be Reconsidered in Case of Microvascular Invasion and Multilocular Tumor Occurrence
by: Jan-Paul Gundlach, et al.
Published: (2021-03-01)

Individualism reconsidered
by: Crittenden, W
Published: (1988)

Yeavering Reconsidered
by: John T. Smith
Published: (2015-05-01)

Reconsidering Authenticity
by: Faisal Nazir
Published: (2020-02-01)

Shaftesbury Reconsidered
by: Tim Stuart-Buttle
Published: (2015-12-01)

Television reconsidered
by: Schramm, Wilbur
Published: (2008)

Anti-VEGF therapy and the retina: an update
by: Tah, V, et al.
Published: (2015)

Future of anti-VEGF: biosimilars and biobetters
by: Monika Kapur, et al.
Published: (2022-01-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial
by: Adam D. DeVore, et al.
Published: (2018-06-01)

Intraocular Lens Power, Myopia, and the Risk of Nd:YAG Capsulotomy after 15,375 Cataract Surgeries
by: Juha-Matti Lindholm, et al.
Published: (2020-09-01)

One-Year Outcomes Comparison of Anti-VEGF Monotherapy and Combined Anti-VEGF+Photodynamic Therapy for Retinal Angiomatous Proliferation
by: Cem Kesim, et al.
Published: (2017-10-01)

Analysis of Enrollment Criteria in Secondary Schools Using Machine Learning and Data Mining Approach
by: Zain ul Abideen, et al.
Published: (2023-01-01)

Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials
by: Pamela Trillo Aliaga, et al.
Published: (2021-11-01)

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
by: Dai Fukumura, et al.
Published: (2023-03-01)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
by: Jacob T. Cox, et al.
Published: (2021-03-01)

Biomarkers as Predictive Factors of Anti-VEGF Response
by: Miriam Bobadilla, et al.
Published: (2022-04-01)

Anti-VEGF Agents and Glaucoma Filtering Surgery
by: Ramin Daneshvar
Published: (2013-01-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Screening and Improvement of an Anti-VEGF DNA Aptamer
by: Kazunori Ikebukuro, et al.
Published: (2010-01-01)

Aid dependence reconsidered
by: Azam, J, et al.
Published: (1999)

Reconsidering migration and class
by: Van Hear, N
Published: (2014)

Reconsidering Jane Jacobs /
by: Page, Max, et al.
Published: (c201)

Reconsidering formative measurement /
by: Howell, Roy D author, et al.
Published: (2007)

The economics of health reconsidered /
by: 384884 Rice, Thomas H.
Published: (2003)

Copy raising reconsidered
by: Nurit Melnik
Published: (2023-12-01)